cagrisema phase 3 results 2025 semaglutide cagrilintide obesity Novo Nordisk shares plunge after drug trial disappoints Novo Nordisk's CagriSema outperforms Ozempic – cagrilintide semaglutide cagrisema semaglutide cagrilintide

It may be useful in certain medical situations, especially confirmed carnitine deficiency, but routine supplementation is not necessary for most healthy people

See our prior blog GLP-1 Drugs: FDA Sued Over Removing Tirzepatide from the Drug Shortage List, dated October 23, 2024

However, compared to that in non-malignant tissues, the expression level of GPx1 in tumor tissues was significantly decreased by 7.4% [83]

As reports of sudden vision loss accumulated, researchers and clinicians began to question whether semaglutide could increase the risk of optic nerve injury in certain patients

If you feel more nauseated when increasing doses, go for a slow titration and schedule small, bland protein snacks instead of skipping doses

Hypoglycaemia (low blood glucose) is uncommon when Ozempic is used as monotherapy, as its glucose-lowering effect is glucose-dependent